Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Learn how a yield-focused dividend ETF can fit into a retirement plan, delivering income while maintaining simplicity and liquidity.
19,425 articlesAmgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Investors eyeing DEI in 2026 should study the Q1 results, leverage, and lease metrics that shape the office REIT's tr...
If you’re weighing SMB vs. VGSH, understanding tax effects and risk is key. This guide breaks down how municipal bond...
EWY has surged in 2026 on AI-driven demand for memory chips, attracting a growing cohort of retirees into the play. T...
Two international small-cap funds, AVDV and DLS, offer different paths to income in a changing 2026 market. This divi...
For years with $1.3 million in retirement savings, income certainty matters more than dramatic gains. Here are three ...
As markets stay volatile in 2026, 1M+ retirement plans hinge on five proven practices. This report distills the secre...
A 58-year-old solo consultant uses a cash balance plan atop a SOLO 401(K) to boost pre-tax retirement sheltering to o...
Volatile markets can derail retirement plans in surprising ways. Learn the biggest withdrawal mistake to avoid and pr...
The latest trustees report signals coming pressures on Social Security. This guide breaks down what that means for ev...
Investors relying on monthly income from the Vanguard Intermediate-Term Corporate Bond Index Fund ETF are evaluating ...
On May 12, 2026, the U.S. welcomed its first spot ETF tied to Hyperliquid's HYPE token. THYP opened on NASDAQ with $1...